Catalog # 제품명 포장단위 중량 Cas No. A 001-2500 Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt 5 x 500 μmol 37839-81-9 A 001-2500 H Adenosine- 3' ,5'- cyclic monophosphate ( cAMP ), free acid form 5 x 500 mg 60-92-4 A 001-500 Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt 500 μmol ~176 mg 37839-81-9 A 001-500 H Adenosine- 3' ,5'- cyclic monophosphate ( cAMP ), free acid form 500 mg ~1.5 mmol 60-92-4 A 002-05 S Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), high purity grade 5 μmol ~1.8 mg 73208-40-9 A 002-05 T Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), economy grade 5 μmol ~2.2 mg 151837-09-1 A 002-25 S Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), high purity grade 5 x 5 μmol 73208-40-9 A 002-25 T Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), economy grade 5 x 5 μmol 151837-09-1 A 003-10 S Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), high purity grade 10 μmol ~3.7 mg 71774-13-5 A 003-10 T Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ) 10 μmol ~4.5 mg 93602-66-5 A 003-50 S Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), high purity grade 5 x 10 μmol 71774-13-5 A 003-50 T Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ) 5 x 10 μmol 93602-66-5 A 005-250 Adenosine- 5'- O- monophosphorothioate ( 5'- AMPS ) 5 x 50 μmol 93839-85-1 A 005-50 Adenosine- 5'- O- monophosphorothioate ( 5'- AMPS ) 50 μmol ~18 mg 93839-85-1 A 006-05 Adenosine- 2', 3'- cyclic monophosphorothioate, Rp- / endo isomer ( Rp-2',3'-cAMPS ) 5 μmol ~1.9 mg 118275-99-3 A 006-25 Adenosine- 2', 3'- cyclic monophosphorothioate, Rp- / endo isomer ( Rp-2',3'-cAMPS ) 5 x 5 μmol 118275-99-3 A 007-06 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AEA-cAMPS-Agarose ) 0.6 ml none A 007-25 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AEA-cAMPS-Agarose ) 2.5 ml none A 007-60 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AEA-cAMPS-Agarose ) 6 ml none A 008-06 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AEA-cAMPS-Agarose ) 0.6 ml none A 008-25 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AEA-cAMPS-Agarose ) 2.5 ml none A 008-60 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AEA-cAMPS-Agarose ) 6 ml none A 009-06 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AET-cGMPS-Agarose ) 0.6 ml none A 009-25 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AET-cGMPS-Agarose ) 2.5 ml none A 009-60 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AET-cGMPS-Agarose ) 6 ml none A 010-06 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AET-cGMPS-Agarose ) 0.6 ml none A 010-25 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AET-cGMPS-Agarose ) 2.5 ml none A 010-60 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AET-cGMPS-Agarose ) 6 ml none A 011-10 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AHA-cAMP ) 10 μmol ~4.4 mg 39824-30-1 A 011-50 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AHA-cAMP ) 5 x 10 μmol 39824-30-1 A 012-06 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AHA-cAMPS-Agarose ) 0.6 ml none A 012-25 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AHA-cAMPS-Agarose ) 2.5 ml none A 012-60 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AHA-cAMPS-Agarose ) 6 ml none A 013-06 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) 0.6 ml none A 013-25 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) 2.5 ml none A 013-60 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) 6 ml none A 014-10 8- Azidoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-cAMP ) 10 μmol ~3.9 mg 31966-52-6 A 014-50 8- Azidoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-cAMP ) 5 x 10 μmol 31966-52-6 A 015-05 2- Aza- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 2-Aza-ε-cAMP ) 5 μmol ~1.9 mg 50663-90-6 A 015-25 2- Aza- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 2-Aza-ε-cAMP ) 5 x 5 μmol 50663-90-6 A 016-05 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AEA-cAMP ) 5 μmol ~1.9 mg 61363-29-9 A 016-25 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AEA-cAMP ) 5 x 5 μmol 61363-29-9 A 017-05 8- (4- Aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ABA-cAMP ) 5 μmol ~2.1 mg 82927-68-2 A 017-25 8- (4- Aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ABA-cAMP ) 5 x 5 μmol 82927-68-2 A 019-06 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AET-cGMP-Agarose ) 0.6 ml none A 019-25 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AET-cGMP-Agarose ) 2.5 ml none A 019-60 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AET-cGMP-Agarose ) 6 ml none A 020-06 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AEA-cAMP-Agarose ) 0.6 ml none A 020-25 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AEA-cAMP-Agarose ) 2.5 ml none A 020-60 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AEA-cAMP-Agarose ) 6 ml none A 021-10 5'- Amino- 5'- deoxyadenosine ( 5'-NH2-Ado ) 10 μmol ~2.7 mg 14365-44-7 A 021-50 5'- Amino- 5'- deoxyadenosine ( 5'-NH2-Ado ) 5 x 10 μmol 14365-44-7 A 022-01 Adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cAMP-AM ) 1 μmol ~0.4 mg 159764-93-9 A 022-05 Adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cAMP-AM ) 5 x 1 μmol 159764-93-9 A 023-05 Adenosine- 1- N- oxid- 3', 5'- cyclic monophosphate 5 μmol ~1.8 mg 75912-25-3 A 023-25 Adenosine- 1- N- oxid- 3', 5'- cyclic monophosphate 5 x 5 μmol 75912-25-3 A 024-05 Adenosine- 2', 3'- cyclic monophosphorothioate, Sp- / exo isomer ( Sp-2',3'-cAMPS ) 5 μmol ~1.9 mg 118276-00-9 A 024-25 Adenosine- 2', 3'- cyclic monophosphorothioate, Sp- / exo isomer ( Sp-2',3'-cAMPS ) 5 x 5 μmol 118276-00-9 A 026-05 N6- (4- Aminobutyl)adenosine- 5'- O- diphosphate ( 6-AB-ADP ) 5 μmol ~2.5 mg 767272-34-4 A 026-25 N6- (4- Aminobutyl)adenosine- 5'- O- diphosphate ( 6-AB-ADP ) 5 x 5 μmol 767272-34-4 A 027-05 2- Aminopurine riboside- 3', 5'- monophosphate ( 2-NH2-cPuMP ) 5 μmol ~1.8 mg 42467-66-3 A 027-25 2- Aminopurine riboside- 3', 5'- monophosphate ( 2-NH2-cPuMP ) 5 x 5 μmol 42467-66-3 A 028-06 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP Agarose ) 0.6 ml none A 028-25 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP Agarose ) 2.5 ml none A 028-60 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP Agarose ) 6 ml none A 029-05 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AET-cGMP ) 5 μmol ~2.1 mg 115974-70-4 A 029-25 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AET-cGMP ) 5 x 5 μmol 115974-70-4 A 031-05 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AH-cAMP ) 5 μmol ~2.1 mg 66311-09-9 A 031-25 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AH-cAMP ) 5 x 5 μmol 66311-09-9 A 032-05 8- (2- Aminophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-APT-cGMP ) 5 μmol ~2.4 mg 144509-87-5 A 032-25 8- (2- Aminophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-APT-cGMP ) 5 x 5 μmol 144509-87-5 A 033-05 8- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ADOA-cAMP ) 5 μmol ~2.4 mg 214272-05-6 A 033-25 8- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ADOA-cAMP ) 5 x 5 μmol 214272-05-6 A 035-01 Adenosine- 3', 5'- monophosphorothioate acetoxymethyl ester, Sp- isomer ( Sp-cAMPS-AM ) 1 μmol ~0.4 mg 152218-24-1 A 035-05 Adenosine- 3', 5'- monophosphorothioate acetoxymethyl ester, Sp- isomer ( Sp-cAMPS-AM ) 5 x 1 μmol 152218-24-1 A 036-06 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP Agarose ) 0.6 ml none A 036-25 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP Agarose ) 2.5 ml none A 036-60 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP Agarose ) 6 ml none A 037-05 Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-ADP-α-S ) 5 μmol ~2.2 mg 59331-71-4 A 037-25 Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-ADP-α-S ) 5 x 5 μmol 59331-71-4 A 038-05 Adenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-ADP-α-S ) 5 μmol ~2.2 mg 59286-20-3 A 038-25 Adenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-ADP-α-S ) 5 x 5 μmol 59286-20-3 A 039-05 Adenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-ATP-α-S ) 5 μmol ~2.6 mg 58976-49-1 A 039-25 Adenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-ATP-α-S ) 5 x 5 μmol 58976-49-1 A 040-05 Adenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-ATP-α-S ) 5 μmol ~2.6 mg 35094-46-3 A 040-25 Adenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-ATP-α-S ) 5 x 5 μmol 35094-46-3 A 041-05 N1- Aminoguanosine- 3', 5'- cyclic monophosphate ( 1-NH2-cGMP ) 5 μmol ~1.9 mg 78033-42-8 A 041-25 N1- Aminoguanosine- 3', 5'- cyclic monophosphate ( 1-NH2-cGMP ) 5 x 5 μmol 78033-42-8 A 043-05 8- Azidoadenosine- 5'- O- triphosphate ( 8-N3-ATP ) 5 μmol ~2.7 mg 53696-59-6 A 043-25 8- Azidoadenosine- 5'- O- triphosphate ( 8-N3-ATP ) 5 x 5 μmol 53696-59-6 A 044-05 8- Azidoadenosine- 5'- O- diphosphate ( 8-N3-ADP ) 5 μmol ~2.3 mg 59432-65-4 A 044-25 8- Azidoadenosine- 5'- O- diphosphate ( 8-N3-ADP ) 5 x 5 μmol 59432-65-4 A 045-100 8- Azidoadenosine ( 8-N3-Ado ) 100 μmol ~31 mg 4372-67-2 A 045-500 8- Azidoadenosine ( 8-N3-Ado ) 5 x 100 μmol 4372-67-2 A 046-05 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cAMP ) 5 μmol ~2.4 mg pending A 046-25 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cAMP ) 5 x 5 μmol pending A 048-05 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cGMP ) 5 μmol ~2.4 mg pending A 048-25 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cGMP ) 5 x 5 μmol pending A 050-06 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) 0.6 ml none A 050-25 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) 2.5 ml none A 050-60 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) 6 ml none A 051-06 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) 0.6 ml none A 051-25 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) 2.5 ml none A 051-60 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) 6 ml none A 052-06 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) 0.6 ml none A 052-25 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) 2.5 ml none A 052-60 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) 6 ml none A 053-05 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AHA-cAMP ) 5 μmol ~2.2 mg 214276-80-9 A 053-25 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AHA-cAMP ) 5 x 5 μmol 214276-80-9 A 054-06 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AHA-cAMP-Agarose ) 0.6 ml none A 054-25 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AHA-cAMP-Agarose ) 2.5 ml none A 054-60 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AHA-cAMP-Agarose ) 6 ml none A 055-05 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-AH-cGMP ) 5 μmol ~2.2 mg 205368-58-7 A 055-25 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-AH-cGMP ) 5 x 5 μmol 205368-58-7 A 056-06 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AH-cGMP Agarose ) 0.6 ml none A 056-25 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AH-cGMP Agarose ) 2.5 ml none A 056-60 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AH-cGMP Agarose ) 6 ml none A 057-06 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cylic monophosphate, immobilized on agarose ( 8-AHA-2'-O-Me-cAMP-Agarose ) 0.6 ml none A 057-25 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cylic monophosphate, immobilized on agarose ( 8-AHA-2'-O-Me-cAMP-Agarose ) 2.5 ml none A 057-60 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cylic monophosphate, immobilized on agarose ( 8-AHA-2'-O-Me-cAMP-Agarose ) 6 ml none A 058-06 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cAMP-Agarose ) 0.6 ml none A 058-25 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cAMP-Agarose ) 2.5 ml none A 058-60 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cAMP-Agarose ) 6 ml none A 059-06 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cGMP-Agarose ) 0.6 ml none A 059-25 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cGMP-Agarose ) 2.5 ml none A 059-60 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cGMP-Agarose ) 6 ml none A 060-05 Adenosine- 5'- O- (3- thiotriphosphate) ( ATP-γ-S ) 5 μmol ~2.6 mg 93839-89-5 A 060-25 Adenosine- 5'- O- (3- thiotriphosphate) ( ATP-γ-S ) 5 x 5 μmol 93839-89-5 A 061-10 Adenosine- 5'- O- phosphosulfate ( APS ) 10 μmol ~4.3 mg 102029-95-8 A 061-50 Adenosine- 5'- O- phosphosulfate ( APS ) 5 x 10 μmol 102029-95-8 A 063-10 3'- Amino- 3'- deoxyadenosine ( 3'-AdA ) 10 μmol ~2.7 mg 2504-55-4 A 063-50 3'- Amino- 3'- deoxyadenosine ( 3'-AdA ) 5 x 10 μmol 2504-55-4 A 064-10 3'- Amino- 3'- deoxyguanosine ( 3'-AdG ) 10 μmol ~2.8 mg 80015-76-5 A 064-50 3'- Amino- 3'- deoxyguanosine ( 3'-AdG ) 5 x 10 μmol 80015-76-5 A 065-01 Adenosine- 3', 5'- cyclic monophosphate, benzyl ester ( cAMP-Bn ) 1 μmol ~0.4 mg 62742-71-6 A 065-05 Adenosine- 3', 5'- cyclic monophosphate, benzyl ester ( cAMP-Bn ) 5 x 1 μmol 62742-71-6 A 066-05 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cAMPS ) 5 μmol ~2.4 mg pending A 066-25 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cAMPS ) 5 x 5 μmol pending A 067-05 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cGMPS ) 5 μmol ~2.5 mg pending A 067-25 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cGMPS ) 5 x 5 μmol pending A 068-05 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AHA-cAMPS ) 5 μmol ~2.3 mg 214276-94-5 A 068-25 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AHA-cAMPS ) 5 x 5 μmol 214276-94-5 A 069-06 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized to agarose gel ( Sp-2-AHA-cAMPS-Agarose ) 0.6 ml none A 069-25 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized to agarose gel ( Sp-2-AHA-cAMPS-Agarose ) 2.5 ml none A 069-60 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized to agarose gel ( Sp-2-AHA-cAMPS-Agarose ) 6.0 ml none A 070-05 Adenosine- 5'- O- (α, β- methylenediphosphate) ( AMP-CP / AOPCP ) 5 μmol ~2.1 mg 104835-70-3 A 070-25 Adenosine- 5'- O- (α, β- methylenediphosphate) ( AMP-CP / AOPCP ) 5 x 5 μmol 104835-70-3 A 071-05 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AHA-cAMPS ) 5 μmol ~2.3 mg 214272-03-4 A 071-25 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AHA-cAMPS ) 5 x 5 μmol 214272-03-4 A 072-05 2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AEC-ATP / EDA-ATP ) 5 μmol ~3 mg 173074-70-9 A 072-25 2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AEC-ATP / EDA-ATP ) 5 x 5 μmol 173074-70-9 A 074-05 N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ) 5 μmol ~2.9 mg 280577-98-2 A 074-25 N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ) 5 x 5 μmol 280577-98-2 A 075-05 2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cGMP ) 5 μmol ~2.2 mg pending A 075-25 2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cGMP ) 5 x 5 μmol pending A 076-05 Arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-cAMP ) 5 μmol ~1.8 mg 32465-18-2 A 076-25 Arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-cAMP ) 5 x 5 μmol 32465-18-2 A 077-01 8- Azido- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-ε-cAMP ) 1 μmol ~0.4 mg 60902-12-7 A 077-05 8- Azido- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-ε-cAMP ) 5 x 1 μmol 60902-12-7 A 084-05 2- Amino- 6- chloropurine riboside- 5'- O- monophosphate ( 2-NH2-6-Cl-5'-PuMP ) 5 μmol ~1.9 mg pending A 084-25 2- Amino- 6- chloropurine riboside- 5'- O- monophosphate ( 2-NH2-6-Cl-5'-PuMP ) 5 x 5 μmol pending A 085-05 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AHA-cAMPS ) 5 μmol ~2.3 mg 214272-02-3 A 085-25 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AHA-cAMPS ) 5 x 5 μmol 214272-02-3 A 086-10 2- Aza- 1, N6- ethenoadenosine ( 2-Aza-ε-Ado ) 10 μmol ~2.9 mg 50663-82-6 A 086-50 2- Aza- 1, N6- ethenoadenosine ( 2-Aza-ε-Ado ) 5 x 10 μmol 50663-82-6 A 087-06 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) 0.6 ml none A 087-25 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) 2.5 ml none A 087-60 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) 6 ml none A 088-05 2'- Amino- 2'- deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-NH2-cAMP ) 5 μmol ~1.8 mg 85819-83-6 A 088-25 2'- Amino- 2'- deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-NH2-cAMP ) 5 x 5 μmol 85819-83-6 A 089-05 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AH-cAMPS ) 5 μmol ~2.2 mg pending A 089-25 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AH-cAMPS ) 5 x 5 μmol pending A 092-05 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AE-cAMPS ) 5 μmol ~1.9 mg pending A 092-25 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AE-cAMPS ) 5 x 5 μmol pending A 093-05 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AEA-cAMPS ) 5 μmol ~2 mg pending A 093-25 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AEA-cAMPS ) 5 x 5 μmol pending A 094-05 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AEA-cAMPS ) 5 μmol ~2 mg 221904-84-3 A 094-25 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AEA-cAMPS ) 5 x 5 μmol 221904-84-3 A 095-05 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AEC-cAMPS / Sp-2'-EDA-cAMPS ) 5 μmol ~2.2 mg pending A 095-25 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AEC-cAMPS / Sp-2'-EDA-cAMPS ) 5 x 5 μmol pending A 096-05 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AE-cAMP ) 5 μmol ~1.9 mg 66311-08-8 A 096-25 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AE-cAMP ) 5 x 5 μmol 66311-08-8 A 097-05 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AEA-cAMP ) 5 μmol ~1.9 mg 66311-12-4 A 097-25 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AEA-cAMP ) 5 x 5 μmol 66311-12-4 A 098-05 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cAMP / 2'-EDA-cAMP ) 5 μmol ~2.1 mg 403497-54-1 A 098-25 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cAMP / 2'-EDA-cAMP ) 5 x 5 μmol 403497-54-1 A 099-05 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2'-O-Me-cAMP ) 5 μmol 2.3 mg pending A 099-25 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2'-O-Me-cAMP ) 5 x 5 μmol pending A 100-001 8- Azido- N6- (2- [DY-547]- aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[DY-547]-AE-cAMP ) 0.1 μmol ~0.1 mg pending A 100-005 8- Azido- N6- (2- [DY-547]- aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[DY-547]-AE-cAMP ) 5 x 0.1 μmol pending A 101-01 N6- (2- Aminoethyl)- 8- azidoadenosine- 3', 5'- cyclic monophosphate ( 6-AE-8-N3-cAMP ) 1 μmol ~0.4 mg pending A 101-05 N6- (2- Aminoethyl)- 8- azidoadenosine- 3', 5'- cyclic monophosphate ( 6-AE-8-N3-cAMP ) 5 x 1 μmol pending A 102-01 beta- (4- Azidophenyl)- 1, N2- etheno- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-Br-cGMP ) 1 μmol ~0.6 mg pending A 102-05 beta- (4- Azidophenyl)- 1, N2- etheno- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-Br-cGMP ) 5 x 1 μmol pending A 103-10 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside ( AICAR / Acadesine / Z- riboside ) 10 μmol ~2.6 mg 2627-69-2 A 103-50 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside ( AICAR / Acadesine / Z- riboside ) 5 x 10 μmol 2627-69-2 A 104-10 2'- Amino- 2'- deoxyadenosine ( 2'-AdA ) 10 μmol ~2.7 mg 10414-81-0 A 104-50 2'- Amino- 2'- deoxyadenosine ( 2'-AdA ) 5 x 10 μmol 10414-81-0 A 105-10 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside- 5'- O- monophosphate ( AICAR-5'-MP / ZMP ) 10 μmol ~3.4 mg 3031-94-5 A 105-50 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside- 5'- O- monophosphate ( AICAR-5'-MP / ZMP ) 5 x 10 μmol 3031-94-5 A 106-05 2'- Amino- 2'- deoxyadenosine- 5'- O- diphosphate ( 2'-NH2-ADP ) 5 μmol ~2.1 mg 63545-57-3 A 106-25 2'- Amino- 2'- deoxyadenosine- 5'- O- diphosphate ( 2'-NH2-ADP ) 5 x 5 μmol 63545-57-3 A 107-05 3'- Amino- 3'- deoxyadenosine- 5'- O- diphosphate ( 3'-NH2-ADP ) 5 μmol ~2.1 mg [4360-06-9] A 107-25 3'- Amino- 3'- deoxyadenosine- 5'- O- diphosphate ( 3'-NH2-ADP ) 5 x 5 μmol [4360-06-9] A 108-06 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) 0.6 ml none A 108-25 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) 2.5 ml none A 108-60 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) 6 ml none A 109-06 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) 0.6 ml none A 109-25 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) 2.5 ml none A 109-60 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) 6 ml none A 110-06 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) 0.6 ml none A 110-25 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) 2.5 ml none A 110-60 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) 6 ml none A 111-06 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) 0.6 ml none A 111-25 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) 2.5 ml none A 111-60 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) 6 ml none A 112-06 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) 0.6 ml none A 112-25 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) 2.5 ml none A 112-60 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) 6 ml none A 113-05 2'- Amino- 2'- deoxyadenosine- 5'- O- triphosphate ( 2'-NH2-ATP ) 5 μmol ~2.5 mg 61468-88-0 A 113-25 2'- Amino- 2'- deoxyadenosine- 5'- O- triphosphate ( 2'-NH2-ATP ) 5 x 5 μmol 61468-88-0 A 114-05 3'- Amino- 3'- deoxyadenosine- 5'- O- triphosphate ( 3'-NH2-ATP ) 5 μmol ~2.5 mg 4209-30-7 A 114-25 3'- Amino- 3'- deoxyadenosine- 5'- O- triphosphate ( 3'-NH2-ATP ) 5 x 5 μmol 4209-30-7 A 115-05 8- Aminoadenosine- 5'- O- triphosphate ( 8-NH2-ATP ) 5 μmol ~2.6 mg 35874-49-8 A 115-25 8- Aminoadenosine- 5'- O- triphosphate ( 8-NH2-ATP ) 5 x 5 μmol 35874-49-8 A 116-05 5- (3- Aminoallyl)- 2'- deoxyuridine- 5'- O- triphosphate ( AA-dUTP ) 5 μmol ~2.6 mg 109921-28-0 A 116-25 5- (3- Aminoallyl)- 2'- deoxyuridine- 5'- O- triphosphate ( AA-dUTP ) 5 x 5 μmol 109921-28-0 A 117-05 5- (3- Aminoallyl)uridine- 5'- O- triphosphate ( AA-UTP ) 5 μmol ~2.7 mg 75221-88-4 A 117-25 5- (3- Aminoallyl)uridine- 5'- O- triphosphate ( AA-UTP ) 5 x 5 μmol 75221-88-4 A 118-05 2'- /3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- diphosphate ( 2'-/3'-AEC-ADP / EDA-ADP ) 5 μmol ~2.6 mg pending A 118-25 2'- /3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- diphosphate ( 2'-/3'-AEC-ADP / EDA-ADP ) 5 x 5 μmol pending A 119-05 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AEC-cAMPS / Rp-2'-EDA-cAMPS ) 5 μmol ~2.2 mg pending A 119-25 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AEC-cAMPS / Rp-2'-EDA-cAMPS ) 5 x 5 μmol pending A 120-05 2'- O- (6-?Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cAMPS ) 5 μmol ~2.4 mg pending A 120-25 2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cAMPS ) 5 x 5 μmol pending A 121-05 Adenosine- 5'- O- (2- thiodiphosphate) ( ADP-β-S ) 5 μmol ~2.2 mg 35094-45-2 A 121-25 Adenosine- 5'- O- (2- thiodiphosphate) ( ADP-β-S ) 5 x 5 μmol 35094-45-2 A 122-06 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) 0.6 ml none A 122-25 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) 2.5 ml none A 122-60 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) 6 ml none A 123-05 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cGMPS ) 5 μmol ~2.5 mg none A 123-25 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cGMPS ) 5 x 5 μmol none A 124-05 2- Aminopurine riboside- 5'- O- triphosphate ( 2-NH2-PuTP ) 5 μmol ~2.5 mg 23001-60-7 A 124-25 2- Aminopurine riboside- 5'- O- triphosphate ( 2-NH2-PuTP ) 5 x 5 μmol 23001-60-7 A 127-001 8- Azido- N6- (6- [biotinyl]aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[Biotin]-AE-cAMP ) 0.1 μmol ~80 μg pending A 127-005 8- Azido- N6- (6- [biotinyl]aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[Biotin]-AE-cAMP ) 5 x 0.1 μmol pending A 136-05 2- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-ADOA-cAMP ) 5 μmol ~2.4 mg pending A 136-25 2- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-ADOA-cAMP ) 5 x 5 μmol pending A 140-005 8- (2- Aminoethylthio)- cyclic inosine diphosphate ribose ( 8-AET-N1-cIDPR ), sodium salt 0.5 μmol ~309 μg pending A 140-025 8- (2- Aminoethylthio)- cyclic inosine diphosphate ribose ( 8-AET-N1-cIDPR ), sodium salt 5 x 0.5 μmol pending B 001-05 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cAMPS ) 5 μmol ~2.2 mg 129735-00-8 B 001-25 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cAMPS ) 5 x 5 μmol 129735-00-8 B 002-05 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ) 5 μmol ~2.2 mg 127634-20-2 B 002-25 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ) 5 x 5 μmol 127634-20-2 B 004-250 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), fluorescence grade 5 x 50 μmol 51116-01-9 B 004-250 E 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), economy grade 5 x 50 mg 51116-01-9 B 004-50 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), fluorescence grade 50 μmol ~22 mg 51116-01-9 B 004-50 E 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), economy grade 50 mg ~111 μmol 51116-01-9 B 005-05 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cGMPS ) 5 μmol ~2.3 mg 150418-07-8 B 005-25 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cGMPS ) 5 x 5 μmol 150418-07-8 B 006-10 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cGMPS ) 10 μmol ~4.6 mg 153660-03-8 B 006-50 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cGMPS ) 5 x 10 μmol 153660-03-8 B 007-100 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), fluorescence grade 100 μmol ~43 mg 76939-46-3 B 007-250 E 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), economy grade 5 x 50 mg 76939-46-3 B 007-50 E 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), economy grade 50 mg ~116 μmol 76939-46-3 B 007-500 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), fluorescence grade 5 x 100 μmol 76939-46-3 B 008-10 N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ) 10 μmol ~4.4 mg 32115-08-5 B 008-50 N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ) 5 x 10 μmol 32115-08-5 B 009-10 N6- Benzoyladenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-cAMP ) 10 μmol ~4.6 mg 30275-80-0 B 009-50 N6- Benzoyladenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-cAMP ) 5 x 10 μmol 30275-80-0 B 010-05 8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS ) 5 μmol ~2.6 mg 788807-32-9 B 010-25 8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS ) 5 x 5 μmol 788807-32-9 B 012-05 8- Bromoguanosine- 5'- O- triphosphate ( 8-Br-GTP ) 5 μmol ~3 mg 23197-98-0 B 012-25 8- Bromoguanosine- 5'- O- triphosphate ( 8-Br-GTP ) 5 x 5 μmol 23197-98-0 B 013-05 6- Bromotubercidin ( 8- Bromo- 7- deazaadenosine, 6-Br-Tu ) 5 μmol ~1.7 mg 78000-56-3 B 013-25 6- Bromotubercidin ( 8- Bromo- 7- deazaadenosine, 6-Br-Tu ) 5 x 5 μmol 78000-56-3 B 014-01 8- Bromoguanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cGMP-AM ) 1 μmol ~0.5 mg 272445-71-3 B 014-05 8- Bromoguanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cGMP-AM ) 5 x 1 μmol 272445-71-3 B 015-10 8- Benzylthioadenosine- 3', 5'- cyclic monophosphate ( 8-BT-cAMP ) 10 μmol ~4.7 mg 50655-17-9 B 015-50 8- Benzylthioadenosine- 3', 5'- cyclic monophosphate ( 8-BT-cAMP ) 5 x 10 umol 50655-17-9 B 016-001 6, 7- Bis(carboxymethoxy)coumarin- 4- yl)methyl- adenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cAMP ) 0.1 μmol ~68 μg 339291-51-9 B 016-005 6, 7- Bis(carboxymethoxy)coumarin- 4- yl)methyl- adenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cAMP ) 5 x 0.1 μmol 339291-51-9 B 017-001 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- guanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cGMP ) 0.1 μmol ~69 μg 339291-52-0 B 017-005 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- guanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cGMP ) 5 x 0.1 μmol 339291-52-0 B 018-001 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cAMP ) 0.1 μmol ~76 μg 370091-64-8 B 018-005 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cAMP ) 5 x 0.1 μmol 370091-64-8 B 019-001 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cGMP ) 0.1 μmol ~78 μg 370091-68-2 B 019-005 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cGMP ) 5 x 0.1 μmol 370091-68-2 B 020-01 8- Bromoadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cAMP-AM ) 1 μmol ~0.5 mg 190522-24-8 B 020-05 8- Bromoadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cAMP-AM ) 5 x 1 μmol 190522-24-8 B 021-10 8- Bromo- 2'- deoxyguanosine ( 8-Br-dGuo ) 10 μmol ~3.5 mg 13389-03-2 B 021-50 8- Bromo- 2'- deoxyguanosine ( 8-Br-dGuo ) 5 x 10 μmol 13389-03-2 B 022-05 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cAMP ) 5 μmol ~2.2 mg 612513-13-0 B 022-25 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cAMP ) 5 x 5 μmol 612513-13-0 B 023-05 N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ) 5 μmol ~2.6 mg 40811-89-0 B 023-25 N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ) 5 x 5 μmol 40811-89-0 B 024-05 N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ) 5 μmol ~3 mg 40922-97-2 B 024-25 N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ) 5 x 5 μmol 40922-97-2 B 025-01 8- (2- [ Biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cGMP ) 1 μmol ~0.8 mg pending B 025-05 8- (2- [ Biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cGMP ) 5 x 1 μmol pending B 027-10 8- Bromo- 2'- deoxyadenosine ( 8-Br-dAdo ) 10 μmol ~3.3 mg 14985-44-5 B 027-50 8- Bromo- 2'- deoxyadenosine ( 8-Br-dAdo ) 5 x 10 μmol 14985-44-5 B 028-01 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-2'-O-Me-cAMP-AM ) 1 μmol ~0.5 mg pending B 029-01 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, acetoxymethyl ester, Sp- isomer ( Sp-8-Br-cAMPS-AM ) 1 μmol ~0.5 mg pending B 029-05 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, acetoxymethyl ester, Sp- isomer ( Sp-8-Br-cAMPS-AM ) 5 x 1 μmol pending B 030-01 8- (2- [ Biotinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cAMP ) 1 μmol ~0.8 mg pending B 030-05 8- (2- [ Biotinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cAMP ) 5 x 1 μmol pending B 032-01 N2- (6- [ Biotinyl]aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AH-cGMP ) 1 μmol ~0.8 mg pending B 032-05 N2- (6- [ Biotinyl]aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AH-cGMP ) 5 x 1 μmol pending B 037-05 8- Bromo- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cGMP ) 5 μmol ~1.9 mg pending B 037-25 8- Bromo- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cGMP ) 5 x 5 μmol pending B 040-05 N6- Benzoyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Bnz-cAMPS ) 5 μmol ~2.4 mg 152218-18-3 B 040-25 N6- Benzoyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Bnz-cAMPS ) 5 x 5 μmol 152218-18-3 B 041-01 2- (6- [ Biotinyl]aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-Biotin-AHA-cAMP ) 1 μmol ~0.8 mg pending B 041-05 2- (6- [ Biotinyl]aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-Biotin-AHA-cAMP ) 5 x 1 μmol pending B 051-05 8- Bromoadenosine- 5'- O- diphosphoribose ( 8-Br-ADPR ), sodium salt 5 μmol ~3.2 mg 59259-77-7 B 051-25 8- Bromoadenosine- 5'- O- diphosphoribose ( 8-Br-ADPR ), sodium salt 5 x 5 μmol 59259-77-7 B 052-10 8- Bromoadenine ( 8-Br-Ade ) 10 μmol ~2.1 mg 6974-78-3 B 052-50 8- Bromoadenine ( 8-Br-Ade ) 5 x 10 μmol 6974-78-3 B 057-10 8- Bromoguanosine- 5'- O- monophosphate ( 8-Br-5'-GMP ) 10 μmol ~4.4 mg 21870-09-7 B 057-50 8- Bromoguanosine- 5'- O- monophosphate ( 8-Br-5'-GMP ) 5 x 10 μmol 21870-09-7 B 058-10 8- Bromoguanine ( 8-Br-Gua ) 10 μmol ~2.3 mg 3066-84-0 B 058-50 8- Bromoguanine ( 8-Br-Gua ) 5 x 10 μmol 3066-84-0 B 065-005 8- Bromo- cyclic adenosine diphosphate ribose ( 8-Br-cADPR ) 0.5 μmol ~310 μg 151898-26-9 B 065-025 8- Bromo- cyclic adenosine diphosphate ribose ( 8-Br-cADPR ) 5 x 0.5 μmol 151898-26-9 B 066-10 8- Bromoadenosine- 5'- O- monophosphate ( 8-Br-5'-AMP ) 10 μmol ~4.3 mg 23567-96-6 B 066-50 8- Bromoadenosine- 5'- O- monophosphate ( 8-Br-5'-AMP ) 5 x 10 μmol 23567-96-6 B 067-05 8- Bromoadenosine- 5'- O- diphosphate ( 8-Br-ADP ) 5 μmol ~2.5 mg 23600-16-0 B 067-25 8- Bromoadenosine- 5'- O- diphosphate ( 8-Br-ADP ) 5 x 5 μmol 23600-16-0 B 068-05 8- Bromoadenosine- 5'- O- triphosphate ( 8-Br-ATP ) 5 μmol ~2.9 mg 23567-97-7 B 068-25 8- Bromoadenosine- 5'- O- triphosphate ( 8-Br-ATP ) 5 x 5 μmol 23567-97-7 B 069-05 8- Bromo- 2'- deoxyadenosine- 5'- O- triphosphate ( 8-Br-dATP ) 5 μmol ~2.9 mg 92410-99-6 B 069-25 8- Bromo- 2'- deoxyadenosine- 5'- O- triphosphate ( 8-Br-dATP ) 5 x 5 μmol 92410-99-6 B 070-05 8- Bromo- 2'- deoxyguanosine- 5'- O- triphosphate ( 8-Br-dGTP ) 5 μmol ~2.9 mg 66891-23-4 B 070-25 8- Bromo- 2'- deoxyguanosine- 5'- O- triphosphate ( 8-Br-dGTP ) 5 x 5 μmol 66891-23-4 B 071-005 8- Bromo- cyclic inosine diphosphate ribose ( 8-Br-N1-cIDPR ) 0.5 μmol 311 μg 638195-70-7 B 071-025 8- Bromo- cyclic inosine diphosphate ribose ( 8-Br-N1-cIDPR ) 5 x 0.5 μmol 638195-70-7 B 072-05 N6- Benzyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Bn-ATP-γ-S ) 5 μmol ~3.1 mg pending B 072-25 N6- Benzyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Bn-ATP-γ-S ) 5 x 5 μmol pending B 076-01 N6- (3- [Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APr-ADP ), sodium salt 1 μmol 0.7 mg B 076-25 N6- (3- [Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APr-ADP ), sodium salt 5 x 1 μmol pending B 077-01 N6- (3- [([Biotinyl]- 3- aminopropoxy(ethoxy)ethoxy)ethoxy]ethoxypropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APrO-(EO)4-Pr-ADP ), sodium salt 1 μmol ~1 mg pending B 077-05 N6- (3- [([Biotinyl]- 3- aminopropoxy(ethoxy)ethoxy)ethoxy]ethoxypropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APrO-(EO)4-Pr-ADP ), sodium salt 5 x 1 μmol pending B 079-01 N6- Benzoyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 6-Bnz-cAMP-AM ) 1 μmol ~0.5 mg [pending] B 079-05 N6- Benzoyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 6-Bnz-cAMP-AM ) 5 x 1 μmol [pending] B 082-005 8- Bromoinosine- 5'- O- diphosphoribose ( 8-Br-IDPR ), sodium salt 0.5 μmol ~320 μg pending B 082-025 8- Bromoinosine- 5'- O- diphosphoribose ( 8-Br-IDPR ), sodium salt 5 x 0.5 μmol pending C 001-250 Cytidine- 3', 5'- cyclic monophosphate ( cCMP ) 5 x 50 μmol 54925-33-6 C 001-50 Cytidine- 3', 5'- cyclic monophosphate ( cCMP ) 50 μmol ~16 mg 54925-33-6 C 002-05 6- Chloropurine riboside- 3', 5'- cyclic monophosphate ( 6-Cl-cPuMP ) 5 μmol ~1.9 mg 94200-58-5 C 002-25 6- Chloropurine riboside- 3', 5'- cyclic monophosphate ( 6-Cl-cPuMP ) 5 x 5 μmol 94200-58-5 C 003-05 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ) 5 μmol ~2 mg 142754-27-6 C 003-25 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ) 5 x 5 μmol 142754-27-6 C 004-05 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Cl-cAMPS ) 5 μmol ~2 mg 142754-28-7 C 004-25 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Cl-cAMPS ) 5 x 5 μmol 142754-28-7 C 005-005 Cyclic adenosine diphosphate ribose ( cADPR ) 0.5 μmol ~270 μg 119340-53-3 C 005-025 Cyclic adenosine diphosphate ribose ( cADPR ) 5 x 0.5 μmol 119340-53-3 C 006-10 8- Chloroadenosine ( 8-Cl-Ado ) 10 μmol ~3 mg 34408-14-5 C 006-50 8- Chloroadenosine ( 8-Cl-Ado ) 5 x 10 μmol 34408-14-5 C 007-10 8- Chloroadenosine- 3', 5'- cyclic monophosphate ( 8-Cl-cAMP ) 10 μmol ~3.9 mg 41941-56-4 C 007-50 8- Chloroadenosine- 3', 5'- cyclic monophosphate ( 8-Cl-cAMP ) 5 x 10 μmol 41941-56-4 C 009-10 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), fluorescence grade 10 μmol ~5 mg 51239-26-0 C 009-10 E 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), economy grade 10 mg ~19 μmol 51239-26-0 C 009-50 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), fluorescence grade 5 x 10 μmol 51239-26-0 C 009-50 E 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), economy grade 5 x 10 mg 51239-26-0 C 010-100 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), fluorescence grade 100 μmol ~49 mg 93882-12-3 C 010-250 E 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), economy grade 5 x 50 mg 93882-12-3 C 010-50 E 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), economy grade 50 mg ~102 μmol 93882-12-3 C 010-500 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), fluorescence grade 5 x 100 μmol 93882-12-3 C 011-05 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-CPT-cAMPS ) 5 μmol ~2.5 mg 129735-01-9 C 011-25 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-CPT-cAMPS ) 5 x 5 μmol 129735-01-9 C 012-05 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-CPT-cAMPS ) 5 μmol ~2.5 mg 129693-13-6 C 012-25 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-CPT-cAMPS ) 5 x 5 μmol 129693-13-6 C 013-01 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-cGMPS ) 1 μmol ~0.5 mg 153660-04-9 C 013-05 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-cGMPS ) 5 x 1 μmol 153660-04-9 C 014-05 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ) 5 μmol ~2.6 mg 160385-87-5 C 014-25 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ) 5 x 5 μmol 160385-87-5 C 015-05 6- Chloropurine riboside- 5'- O- diphosphate ( 6-Cl-PuDP ) 5 μmol ~2.2 mg 59128-86-8 C 015-25 6- Chloropurine riboside- 5'- O- diphosphate ( 6-Cl-PuDP ) 5 x 5 μmol 59128-86-8 C 016-05 8- Chloroadenosine- 5'- O- monophosphate ( 8-Cl-5'-AMP ) 5 μmol ~1.9 mg 37676-40-7 C 016-25 8- Chloroadenosine- 5'- O- monophosphate ( 8-Cl-5'-AMP ) 5 x 5 μmol 37676-40-7 C 017-100 2- Chloroadenosine ( 2-Cl-Ado ) 100 μmol ~30 mg 146-77-0 C 017-500 2- Chloroadenosine ( 2-Cl-Ado ) 5 x 100 μmol 146-77-0 C 018-05 8- Chloroadenosine- 5'- O- triphosphate ( 8-Cl-ATP ) 5 μmol ~2.7 mg 185341-71-3 C 018-25 8- Chloroadenosine- 5'- O- triphosphate ( 8-Cl-ATP ) 5 x 5 μmol 185341-71-3 C 019-05 8- Chloroinosine ( 8-Cl-Ino ) 5 μmol ~1.5 mg 116285-77-9 C 019-25 8- Chloroinosine ( 8-Cl-Ino ) 5 x 5 μmol 116285-77-9 C 020-05 2- Chloroadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-cAMP ) 5 μmol ~1.9 mg 39023-65-9 C 020-25 2- Chloroadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-cAMP ) 5 x 5 μmol 39023-65-9 C 021-10 2- Chloroinosine ( 2-Cl-Ino ) 10 μmol ~3 mg 13276-43-2 C 021-50 2- Chloroinosine ( 2-Cl-Ino ) 5 x 10 μmol 13276-43-2 C 022-10 N6- Carbamoylthreonyladenosine ( t6-Ado ) 10 μmol ~4.3 mg 24719-82-2 C 022-50 N6- Carbamoylthreonyladenosine ( t6-Ado ) 5 x 10 μmol 24719-82-2 C 023-10 8- Chloroadenine ( 8-Cl-Ade ) 10 μmol ~1.7 mg 28128-28-1 C 023-50 8- Chloroadenine ( 8-Cl-Ade ) 5 x 10 μmol 28128-28-1 C 024-05 8- Chloro- 2'- deoxyadenosine ( 8-Cl-d-Ado ) 5 μmol ~1.4 mg 85562-55-6 C 024-25 8- Chloro- 2'- deoxyadenosine ( 8-Cl-d-Ado ) 5 x 5 μmol 85562-55-6 C 025-05 8- Chloro- 2'- deoxyguanosine ( 8-Cl-dGuo ) 5 μmol ~1.5 mg 437715-62-3 C 025-25 8- Chloro- 2'- deoxyguanosine ( 8-Cl-dGuo ) 5 x 5 μmol 437715-62-3 C 026-05 8- Chloroguanosine ( 8-Cl-Guo ) 5 μmol ~1.6 mg 2104-68-9 C 026-25 8- Chloroguanosine ( 8-Cl-Guo ) 5 x 5 μmol 2104-68-9 C 027-10 8- Chloroguanine ( 8-Cl-Gua ) 10 μmol ~1.9 mg 22052-03-5 C 027-50 8- Chloroguanine ( 8-Cl-Gua ) 5 x 10 μmol 22052-03-5 C 028-100 2- Chloro- 2'- deoxyadenosine ( 2-Cl-dAdo, Cladribine ) 100 μmol ~29 mg 4291-63-8 C 028-500 2- Chloro- 2'- deoxyadenosine ( 2-Cl-dAdo, Cladribine ) 5 x 100 μmol 4291-63-8 C 029-05 2- Chloroinosine- 3', 5'- cyclic monophosphate ( 2-Cl-cIMP ) 5 μmol ~1.9 mg 52301-30-1 C 029-25 2- Chloroinosine- 3', 5'- cyclic monophosphate ( 2-Cl-cIMP ) 5 x 5 μmol 52301-30-1 C 032-10 6- Chloropurine riboside- 5'- O- monophosphate ( 6-Cl-5'-PuMP ) 10 μmol ~3.7 mg 5843-59-4 C 032-50 6- Chloropurine riboside- 5'- O- monophosphate ( 6-Cl-5'-PuMP ) 5 x 10 μmol 5843-59-4 C 033-01 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-cGMP-AM ) 1 μmol ~0.6 mg 272445-72-4 C 033-05 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-cGMP-AM ) 5 x 1 μmol 272445-72-4 C 034-05 5- Chlorocytidine ( 5-C-C ) 5 μmol ~1.4 mg 25130-29-4 C 034-25 5- Chlorocytidine ( 5-C-C ) 5 x 5 μmol 25130-29-4 C 035-05 5- Chlorouridine ( 5-Cl-U ) 5 μmol ~1.4 mg 2880-89-9 C 035-25 5- Chlorouridine ( 5-Cl-U ) 5 x 5 μmol 2880-89-9 C 039-05 2- Chloroadenosine- 5'- O- triphosphate ( 2-Cl-ATP ) 5 μmol ~2.7 mg 49564-60-5 C 039-25 2- Chloroadenosine- 5'- O- triphosphate ( 2-Cl-ATP ) 5 x 5 μmol 49564-60-5 C 040-10 2- Chloroadenine ( 2-Cl-Ade ) 10 μmol ~1.7 mg 1839-18-5 C 040-50 2- Chloroadenine ( 2-Cl-Ade ) 5 x 10 μmol 1839-18-5 C 041-05 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cAMP / "007" ) 5 μmol ~2.5 mg 510774-50-2 C 041-25 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cAMP / "007" ) 5 x 5 μmol 510774-50-2 C 042-05 8- Chloroadenosine- 5'- O- diphosphate ( 8-Cl-5'-ADP ) 5 μmol ~2.3 mg 185341-69-9 C 042-25 8- Chloroadenosine- 5'- O- diphosphate ( 8-Cl-5'-ADP ) 5 x 5 μmol 185341-69-9 C 043-05 8- (4- Chlorophenylthio)- N6- phenyladenosine- 3', 5'- cyclic monophosphate ( 8-CPT-6-Phe-cAMP ) 5 μmol ~2.8 mg 72549-36-1 C 043-25 8- (4- Chlorophenylthio)- N6- phenyladenosine- 3', 5'- cyclic monophosphate ( 8-CPT-6-Phe-cAMP ) 5 x 5 μmol 72549-36-1 C 044-10 8- Chloroxanthine ( 8-Cl-X ) 10 μmol ~1.9 mg 13548-68-0 C 044-50 8- Chloroxanthine ( 8-Cl-X ) 5 x 10 μmol 13548-68-0 C 045-05 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-PET-cGMP ) 5 μmol ~3 mg pending C 045-25 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-PET-cGMP ) 5 x 5 μmol pending C 046-01 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-PET-cGMPS ) 1 μmol ~0.6 mg pending C 046-05 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-PET-cGMPS ) 5 x 1 μmol pending C 047-01 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-PET-cGMPS ) 1 μmol ~0.6 mg pending C 047-05 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-PET-cGMPS ) 5 x 1 μmol pending C 048-05 8- (4- Chlorophenylthio)- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cGMP ) 5 μmol ~2.6 mg 625112-42-7 C 048-25 8- (4- Chlorophenylthio)- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cGMP ) 5 x 5 μmol 625112-42-7 C 049-05 6- Chloropurine riboside- 5'- O- triphosphate ( 6-Cl-PuTP ) 5 μmol ~2.6 mg 55673-61-5 C 049-25 6- Chloropurine riboside- 5'- O- triphosphate ( 6-Cl-PuTP ) 5 x 5 μmol 55673-61-5 C 050-01 8- Chloroadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Cl-cAMP-AM ) 1 μmol ~0.4 mg pending C 050-05 8- Chloroadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Cl-cAMP-AM ) 5 x 1 μmol pending C 051-01 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-2'-O-Me-cAMP-AM ) 1 μmol ~0.6 mg pending C 052-01 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-2'-O-Me-cAMPS ) 1 μmol ~0.5 mg 634208-37-0 C 052-05 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-2'-O-Me-cAMPS ) 5 x 1 μmol 634208-37-0 C 053-05 Cytidine- 5'- O- monophosphorothioate ( 5'-CMPS ) 5 μmol ~1.7 mg 47151-76-8 C 053-25 Cytidine- 5'- O- monophosphorothioate ( 5'-CMPS ) 5 x 5 μmol 47151-76-8 C 054-10 2- Chloroadenosine- 5'- O- monophosphate ( 2-Cl-5'-AMP ) 10 μmol ~3.8 mg 21466-01-3 C 054-50 2- Chloroadenosine- 5'- O- monophosphate ( 2-Cl-5'-AMP ) 5 x 10 μmol 21466-01-3 C 055-05 2- Chloroadenosine- 5'- O- diphosphate ( 2-Cl-5'-ADP ) 5 μmol ~2.3 mg 16506-88-0 C 055-25 2- Chloroadenosine- 5'- O- diphosphate ( 2-Cl-5'-ADP ) 5 x 5 μmol 16506-88-0 C 056-01 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-CPT-cAMP-AM ) 1 μmol ~0.5 mg 663941-66-0 C 056-05 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-CPT-cAMP-AM ) 5 x 1 μmol 663941-66-0 C 057-001 Cyclic diguanosine monophosphate ( c-diGMP ) / cyclic bis ( 3' → 5' ) diguanylic acid 0.1 μmol ~69 μg 61093-23-0 C 057-005 Cyclic diguanosine monophosphate ( c-diGMP ) / cyclic bis ( 3' → 5' ) diguanylic acid 5 x 0.1 μmol 61093-23-0 C 059-05 8- (4- Chlorophenylthio)- 2'- O- methylxanthosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cXMP ) 5 μmol ~2.6 mg pending C 059-25 8- (4- Chlorophenylthio)- 2'- O- methylxanthosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cXMP ) 5 x 5 μmol pending C 061-05 N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP ) 5 μmol ~2.5 mg 681175-79-1 C 061-25 N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP ) 5 x 5 μmol 681175-79-1 C 062-05 N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ) 5 μmol ~2.9 mg 189822-11-5 C 062-25 N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ) 5 x 5 μmol 189822-11-5 C 065-01 Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cCMPS ) 1 μmol ~0.3 mg 87063-79-4 C 065-05 Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cCMPS ) 5 x 1 μmol 87063-79-4 C 066-05 Cytidine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cCMPS ) 5 μmol ~1.7 mg 87063-81-8 C 066-25 Cytidine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cCMPS ) 5 x 5 μmol 87063-81-8 C 067-01 Cytidine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cCMP-AM ) 1 μmol ~0.4 mg pending C 067-05 Cytidine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cCMP-AM ) 5 x 1 μmol pending C 068-05 8- (4- Chlorophenylthio)arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-8-pCPT-cAMP ) 5 μmol ~2.5 mg pending C 068-25 8- (4- Chlorophenylthio)arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-8-pCPT-cAMP ) 5 x 5 μmol pending C 070-10 8- (4- Chlorophenylthio)- 2'- O- methyladenosine ( 8-pCPT-2'-O-Me-Ado ) 10 μmol ~4.2 mg pending C 070-50 8- (4- Chlorophenylthio)- 2'- O- methyladenosine ( 8-pCPT-2'-O-Me-Ado ) 5 x 10 μmol pending C 077-05 Cytidine- 5'- O- (α, β- methylene)diphosphate ( CMP-CP ) 5 μmol ~2 mg 101536-15-6 C 077-25 Cytidine- 5'- O- (α, β- methylene)diphosphate ( CMP-CP ) 5 x 5 μmol 101536-15-6 C 078-05 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 5'- O- monophosphate ( 8-pCPT-2'-O-Me-5'-AMP ) 5 μmol ~2.5 mg pending C 078-25 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 5'- O- monophosphate ( 8-pCPT-2'-O-Me-5'-AMP ) 5 x 5 μmol pending C 079-05 Cytidine- 5'- O- (2- thiodiphosphate) ( CDP-β-S ) 5 μmol ~2.1 mg 497064-72-9 C 079-25 Cytidine- 5'- O- (2- thiodiphosphate) ( CDP-β-S ) 5 x 5 μmol 497064-72-9 C 080-05 2- Chloro- 8- methylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-MA-cAMP ) 5 μmol ~2.1 mg 96990-16-8 C 080-25 2- Chloro- 8- methylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-MA-cAMP ) 5 x 5 μmol 96990-16-8 C 081-05 5- Chloro- 2'- deoxycytidine ( CldC ) 5 μmol ~2.1 mg 32387-56-7 C 081-25 5- Chloro- 2'- deoxycytidine ( CldC ) 5 x 5 μmol 32387-56-7 C 084-05 N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ) 5 μmol ~2.9 mg 206978-73-6 C 084-25 N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ) 5 x 5 μmol 206978-73-6 C 085-05 N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ) 5 μmol ~2.5 mg pending C 085-25 N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ) 5 x 5 μmol pending C 086-10 8- (4- Chlorophenylthio)adenosine ( 8-pCPT-Ado ) 10 μmol ~4.1 mg 85352-87-0 C 086-50 8- (4- Chlorophenylthio)adenosine ( 8-pCPT-Ado ) 5 x 10 μmol 85352-87-0 C 088-001 Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis ( 3' → 5' ) diadenylic acid, sodium salt 0.1 μmol ~66 μg 54447-84-6 C 088-005 Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis ( 3' → 5' ) diadenylic acid, sodium salt 5 x 0.1 μmol 54447-84-6 C 089-05 N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-AMP ) 5 μmol ~2.1 mg 117778-38-8 C 089-25 N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-AMP ) 5 x 5 μmol 117778-38-8 C 092-10 8- Carboxyethylaminoadenosine ( 8-CEA-Ado ) 10 μmol ~3.5 mg pending C 092-50 8- Carboxyethylaminoadenosine ( 8-CEA-Ado ) 5 x 10 μmol pending C 098-005 Cyclic inosine diphosphate ribose ( N1-cIDPR ), sodium salt 0.5 μmol ~271 μg 856702-89-1 C 098-025 Cyclic inosine diphosphate ribose ( N1-cIDPR ), sodium salt 5 x 0.5 μmol 856702-89-1 D 001-05 5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) 5 μmol ~1.8 mg 142754-31-2 D 001-25 5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) 5 x 5 μmol 142754-31-2 D 002-125 2', 3'- Dideoxyadenosine ( ddA ) 5 x 25 μmol 4097-22-7 D 002-25 2', 3'- Dideoxyadenosine ( ddA ) 25 μmol ~5.9 mg 4097-22-7 D 003-05 2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) 5 μmol ~1.7 mg 64145-26-2 D 003-25 2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) 5 x 5 μmol 64145-26-2 D 004-05 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-α-S ) 5 μmol ~2.1 mg 120496-69-7 D 004-25 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-α-S ) 5 x 5 μmol 120496-69-7 D 005-05 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-α-S ) 5 μmol ~2.1 mg 120496-69-7 D 005-25 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-α-S ) 5 x 5 μmol 120496-69-7 D 006-05 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-α-S ) 5 μmol ~2.5 mg 87358-15-4 D 006-25 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-α-S ) 5 x 5 μmol 87358-15-4 D 007-05 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-α-S ) 5 μmol ~2.5 mg 80875-87-2 D 007-25 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-α-S ) 5 x 5 μmol 80875-87-2 D 008-01 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) 1 μmol ~0.5 mg 159910-48-2 D 008-05 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) 5 x 1 μmol 159910-48-2 D 009-100 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade 100 μmol ~49 mg 16980-89-5 D 009-250 E N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade 5 x 50 mg 16980-89-5 D 009-50 E N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade 50 mg ~102 μmol 16980-89-5 D 009-500 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade 5 x 100 μmol 16980-89-5 D 010-250 N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) 5 x 50 μmol 51116-00-8 D 010-50 N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) 50 μmol ~25 mg 51116-00-8 D 011-10 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) 10 μmol ~4 mg 129693-10-3 D 011-50 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) 5 x 10 μmol 129693-10-3 D 012-100 5, 6- Dichlorobenzimidazole riboside (DRB) 100 μmol ~32 mg 53-85-0 D 012-500 5, 6- Dichlorobenzimidazole riboside (DRB) 5 x 100 μmol 53-85-0 D 013-05 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) 5 μmol ~2.1 mg 120912-55-2 D 013-25 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) 5 x 5 μmol 120912-55-2 D 014-05 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) 5 μmol ~2.1 mg 120912-54-1 D 014-25 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) 5 x 5 μmol 120912-54-1 D 015-10 2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) 10 μmol ~3.4 mg 93839-95-3 D 015-50 2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) 5 x 10 μmol 93839-95-3 D 016-100 N², N²- Dimethylguanosine ( M²2Guo ) 100 μmol ~31 mg 2140-67-2 D 016-500 N², N²- Dimethylguanosine ( M²2Guo ) 5 x 100 μmol 2140-67-2 D 018-05 2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) 5 μmol ~2.4 mg 132619-65-9 D 018-25 2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) 5 x 5 μmol 132619-65-9 D 019-05 2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) 5 μmol ~2.5 mg 68726-28-3 D 019-25 2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) 5 x 5 μmol 68726-28-3 D 020-10 2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) 10 μmol ~3.5 mg 93919-42-7 D 020-50 2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) 5 x 10 μmol 93919-42-7 D 021-05 7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) 5 μmol ~1.8 mg 16719-36-1 D 021-25 7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) 5 x 5 μmol 16719-36-1 D 022-05 2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) 5 μmol ~1.5 mg 88847-89-6 D 022-25 2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) 5 x 5 μmol 88847-89-6 D 025-05 2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddGTP-α-S ) 5 μmol ~2.5 mg 154771-50-3 D 025-25 2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddGTP-α-S ) 5 x 5 μmol 154771-50-3 D 026-05 2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- /Sp- isomers ( Rp-/Sp-ddATP-α-S ) 5 μmol ~2.5 mg 154902-26-8 D 026-25 2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- /Sp- isomers ( Rp-/Sp-ddATP-α-S ) 5 x 5 μmol 154902-26-8 D 027-05 2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddCTP-α-S ) 5 μmol ~2.4 mg 154771-49-0 D 027-25 2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddCTP-α-S ) 5 x 5 μmol 154771-49-0 D 028-05 2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate), Rp- / Sp- isomers ( Rp-/Sp-ddUTP-α-S ) 5 μmol ~2.3 mg pending D 028-25 2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate), Rp- / Sp- isomers ( Rp-/Sp-ddUTP-α-S ) 5 x 5 μmol pending D 029-05 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate), Rp-/Sp-isomers ( Rp-/Sp-ddTTP-α-S ) 5 μmol ~2.4 mg 154771-48-9 D 029-25 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate), Rp-/Sp-isomers ( Rp-/Sp-ddTTP-α-S ) 5 x 5 μmol 154771-48-9 D 030-05 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-α-S ) 5 μmol ~2.6 mg 80902-29-0 D 030-25 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-α-S ) 5 x 5 μmol 80902-29-0 D 031-05 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-α-S ) 5 μmol ~2.6 mg 80902-28-9 D 031-25 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-α-S ) 5 x 5 μmol 80902-28-9 D 032-10 7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP/TuMP ) 10 μmol ~3.5 mg 16719-46-3 D 032-50 7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP/TuMP ) 5 x 10 μmol 16719-46-3 D 033-05 7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) 5 μmol ~2.5 mg 67460-15-5 D 033-25 7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) 5 x 5 μmol 67460-15-5 D 037-05 2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) 5 μmol ~2.3 mg 132619-66-0 D 037-25 2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) 5 x 5 μmol 132619-66-0 D 038-05 3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- triphosphate ( ddTTP ) 5 μmol ~2.3 mg 128524-26-5 D 038-25 3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- triphosphate ( ddTTP ) 5 x 5 μmol 128524-26-5 D 039-250 2', 3'- Dideoxyguanosine ( ddG ) 5 x 50 μmol 085326-06-3 D 039-50 2', 3'- Dideoxyguanosine ( ddG ) 50 μmol ~13 mg 085326-06-3 D 040-100 3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) 100 μmol ~23 mg [3416-05-5] D 040-500 3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) 5 x 100 μmol [3416-05-5] D 041-250 3'- Deoxyguanosine ( 3'-dG ) 5 x 50 μmol 3608-58-0 D 041-50 3'- Deoxyguanosine ( 3'-dG ) 50 μmol ~13 mg 3608-58-0 D 042-001 (7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) 0.1 μmol ~58 μg 339291-37-1 D 042-005 (7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) 5 x 0.1 μmol 339291-37-1 D 043-001 (7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) 0.1 μmol ~63 μg 339291-42-8 D 043-005 (7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) 5 x 0.1 μmol 339291-42-8 D 044-001 (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) 0.1 μmol ~60 μg pending D 044-005 (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) 5 x 0.1 μmol pending D 045-001 (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) 0.1 μmol ~60 μg pending D 045-005 (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) 5 x 0.1 μmol pending D 046-05 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-α-S ) 5 μmol ~2.4 mg 80951-76-4 D 046-25 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-α-S ) 5 x 5 μmol 80951-76-4 D 047-05 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-α-S ) 5 μmol ~2.4 mg 80951-75-3 D 047-25 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-α-S ) 5 x 5 μmol 80951-75-3 D 048-05 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-α-S ) 5 μmol ~2.4 mg 170428-85-0 D 048-25 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-α-S ) 5 x 5 μmol 170428-85-0 D 049-05 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-α-S ) 5 μmol ~2.4 mg 170428-85-0 D 049-25 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-α-S ) 5 x 5 μmol 170428-85-0 D 050-05 2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) 5 μmol ~1.3 mg 62471-63-0 D 050-25 2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) 5 x 5 μmol 62471-63-0 D 051-005 PKG inhibitor peptide DT-2 0.5 mg ~0.14 μmol pending D 051-025 PKG inhibitor peptide DT-2 5 x 0.5 mg pending D 052-005 PKG inhibitor peptide DT-3 0.5 mg ~0.16 μmol pending D 052-025 PKG inhibitor peptide DT-3 5 x 0.5 mg pending D 056-05 2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) 5 μmol ~1.8 mg 87358-26-7 D 056-25 2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) 5 x 5 μmol 87358-26-7 D 057-05 2'- Deoxyuridine- 5'- O- monophosphosphorothioate ( 5'-dUMPS ) 5 μmol ~1.6 mg 205379-91-5 D 057-25 2'- Deoxyuridine- 5'- O- monophosphosphorothioate ( 5'-dUMPS ) 5 x 5 μmol 205379-91-5 D 058-05 7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP/dTuMP ) 5 μmol ~1.7 mg 103078-56-4 D 058-25 7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP/dTuMP ) 5 x 5 μmol 103078-56-4 D 059-05 2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) 5 μmol ~1.6 mg 64145-27-3 D 059-25 2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) 5 x 5 μmol 64145-27-3 D 060-05 2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) 5 μmol ~1.7 mg 771477-45-3 D 060-25 2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) 5 x 5 μmol 771477-45-3 D 061-05 7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP ) 5 μmol ~2.1 mg 187478-96-2 D 061-25 7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP ) 5 x 5 μmol 187478-96-2 D 073-05 2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-cAMP ) 5 μmol ~1.8 mg 81356-81-2 D 073-25 2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-cAMP ) 5 x 5 μmol 81356-81-2 D 074-05 2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) 5 μmol ~2.5 mg 73449-07-7 D 074-25 2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) 5 x 5 μmol 73449-07-7 D 075-10 N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) 10 μmol ~4.7 mg 64649-87-2 D 075-50 N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) 5 x 10 μmol 64649-87-2 D 076-05 3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) 5 μmol ~1.3 mg 67313-23-9 D 076-25 3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) 5 x 5 μmol 67313-23-9 D 077-05 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- monophosphate ( ε-5'-dAMP ) 5 μmol ~1.8 mg 60508-81-8 D 078-05 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ε-dATP ) 5 μmol ~2.6 mg 81004-54-8 D 078-25 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ε-dATP ) 5 x 5 μmol 81004-54-8 D 079-05 2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) 5 μmol ~1.3 mg 64183-27-3 D 079-25 2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) 5 x 5 μmol 64183-27-3 D 080-05 2'- Deoxy- 1, N6- ethenoadenosine ( ε-dAdo ) 5 μmol ~1.4 mg 68498-25-9 D 080-25 2'- Deoxy- 1, N6- ethenoadenosine ( ε-dAdo ) 5 x 5 μmol 68498-25-9 D 081-05 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP) 5 μmol ~2.3 mg pending D 081-25 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP) 5 x 5 μmol pending D 082-05 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) 5 μmol ~2.4 mg pending D 082-25 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) 5 x 5 μmol pending D 083-05 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) 5 μmol ~2.7 mg 91828-83-0 D 083-25 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) 5 x 5 μmol 91828-83-0 D 084-05 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) 5 μmol ~2.8 mg 127383-33-9 D 084-25 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) 5 x 5 μmol 127383-33-9 D 085-05 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) 5 μmol ~3.1 mg 128113-53-1 D 085-25 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) 5 x 5 μmol 128113-53-1 D 086-05 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) 5 μmol ~3.2 mg 124615-99-2 D 086-25 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) 5 x 5 μmol 124615-99-2 D 087-001 8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP ) 0.1 μmol ~0.1 mg pending D 087-005 8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP ) 5 x 0.1 μmol pending D 089-001 8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) 0.1 μmol ~0.1 mg pending D 089-005 8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) 5 x 0.1 μmol pending D 090-001 8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) 0.1 μmol ~0.1 mg pending D 090-005 8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) 5 x 0.1 μmol pending D 091-05 7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP ) 5 μmol ~2.1 mg 21080-53-5 D 091-25 7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP ) 5 x 5 μmol 21080-53-5 D 092-05 2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) 5 μmol ~2.1 mg 16174-58-6 D 092-25 2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) 5 x 5 μmol 16174-58-6 D 093-05 2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) 5 μmol 1.9 mg 4682-43-3 D 093-25 2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) 5 x 5 μmol 4682-43-3 D 094-05 2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) 5 μmol ~2.1 mg 16174-59-7 D 094-25 2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) 5 x 5 μmol 16174-59-7 D 096-05 7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) 5 μmol ~2.5 mg 10058-66-9 D 096-25 7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) 5 x 5 μmol 10058-66-9 D 099-05 7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) 5 μmol ~1.8 mg 81611-03-2 D 099-25 7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) 5 x 5 μmol 81611-03-2 D 101-001 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) 0.1 μmol ~0.1 mg pending D 101-005 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) 5 x 0.1 μmol pending E 001-10 1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ) 10 μmol ~3.8 mg 103213-51-0 E 001-50 1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ) 5 x 10 μmol 103213-51-0 E 004-05 1, N6- Ethenoadenosine- 5'- O- triphosphate ( ε-ATP ) 5 μmol ~2.7 mg 60777-99-3 E 004-25 1, N6- Ethenoadenosine- 5'- O- triphosphate ( ε-ATP ) 5 x 5 μmol 60777-99-3 E 005-250 1, N6- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP ) 5 x 50 μmol 103213-41-8 E 005-50 1, N6- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP ) 50 μmol ~21 mg 103213-41-8 E 007-05 1, N6- Ethenoadenosine- 5'- O- diphosphate ( ε-ADP ) 5 μmol ~2.3 mg 103213-52-1 E 007-25 1, N6- Ethenoadenosine- 5'- O- diphosphate ( ε-ADP ) 5 x 5 μmol 103213-52-1 E 010-06 Ethanolamine immobilized on agarose ( EtOHNH2-Agarose ) 0.6 ml pending E 010-25 Ethanolamine immobilized on agarose ( EtOHNH2-Agarose ) 2.5 ml pending E 010-60 Ethanolamine immobilized on agarose ( EtOHNH2-Agarose ) 6 ml pending E 011-10 1, N6- Ethenoadenosine ( ε-Ado ) 10 μmol ~2.9 mg 39007-51-7 E 011-50 1, N6- Ethenoadenosine ( ε-Ado ) 5 x 10 μmol 39007-51-7 E 012-10 1, N6- Ethenoadenine ( ε-Ade ) 10 μmol ~1.6 mg 13875-63-3 E 012-50 1, N6- Ethenoadenine ( ε-Ade ) 5 x 10 μmol 13875-63-3 E 013-10 1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( e-ADPR ), sodium salt 10 μmol ~5.8 mg 69699-76-9 E 013-50 1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( e-ADPR ), sodium salt 5 x 10 μmol 69699-76-9 F 001-01 8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cGMP ) 1 μmol ~0.8 mg pending F 001-05 8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cGMP ) 5 x 1 μmol pending F 002-01 8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cAMP ) 1 μmol ~0.8 mg 293296-57-8 F 002-05 8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cAMP ) 5 x 1 μmol 293296-57-8 F 003-01 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP ) 1 μmol ~0.9 mg pending F 003-05 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP ) 5 x 1 μmol pending F 004-01 2'- (6- [ Fluorescein]aminohexylcarbamoylguanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP ) 1 μmol ~0.9 mg pending F 004-05 2'- (6- [ Fluorescein]aminohexylcarbamoylguanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP ) 5 x 1 μmol pending F 006-05 N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ), sodium salt 5 μmol ~2.5 mg pending F 006-25 N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ), sodium salt 5 x 5 μmol pending F 007-05 N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ), sodium salt 5 μmol ~2.9 mg pending F 007-25 N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ), sodium salt 5 x 5 μmol pending F 008-05 N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-gamma-S ), sodium salt 5 μmol ~3 mg pending F 008-25 N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-gamma-S ), sodium salt 5 x 5 μmol pending G 001-100 Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) 100 μmol ~37 mg 40732-48-7 G 001-500 Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) 5 x 100 μmol 40732-48-7 G 002-01 Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) 1 μmol ~0.4 mg 164007-71-0 G 002-05 Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) 5 x 1 μmol 164007-71-0 G 012-05 Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-α-S ) 5 μmol ~2.3 mg 71481-44-2 G 012-25 Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-α-S ) 5 x 5 μmol 71481-44-2 G 013-05 Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-α-S ) 5 μmol ~2.3 mg 71481-45-3 G 013-25 Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-α-S ) 5 x 5 μmol 71481-45-3 G 014-05 Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-α-S ) 5 μmol ~2.7 mg 81570-50-5 G 014-25 Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-α-S ) 5 x 5 μmol 81570-50-5 G 015-05 Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-α-S ) 5 μmol ~2.7 mg 81570-51-6 G 015-25 Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-α-S ) 5 x 5 μmol 81570-51-6 G 016-05 Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp- cGMPS ) 5 μmol ~1.9 mg 86562-09-6 G 016-25 Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp- cGMPS ) 5 x 5 μmol 86562-09-6 G 017-05 Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) 5 μmol ~1.9 mg 86562-10-9 G 017-25 Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) 5 x 5 μmol 86562-10-9 G 018-10 Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) 10 μmol ~3.8 mg 76310-16-2 G 018-50 Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) 5 x 10 μmol 76310-16-2 G 019-05 Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-γ-S ) 5 μmol ~2.7 mg 37589-80-3 G 019-25 Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-γ-S ) 5 x 5 μmol 37589-80-3 G 023-05 Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-β-S ) 5 μmol ~2.3 mg 71376-97-1 G 023-25 Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-β-S ) 5 x 5 μmol 71376-97-1 G 024-05 Guanosine- 5'- O- (α, β- methylene)diphosphate ( GMP-CP ) 5 μmol ~2.2 mg 32381-15-0 G 024-25 Guanosine- 5'- O- (α, β- methylene)diphosphate ( GMP-CP ) 5 x 5 μmol 32381-15-0 G 025-250 Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ), sodium salt 5 x 50 μmol 15718-49-7 G 025-50 Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ), sodium salt 50 μmol ~18 mg 15718-49-7 H 001-05 8- Hydroxyguanosine ( 8-OH-Guo ) 5 μmol ~1.5 mg 3868-31-3 H 001-25 8- Hydroxyguanosine ( 8-OH-Guo ) 5 x 5 μmol 3868-31-3 H 002-100 8- Hydroxyguanine ( 8-OH-Gua ) 100 μmol ~17 mg 5614-64-2 H 002-500 8- Hydroxyguanine ( 8-OH-Gua ) 5 x 100 μmol 5614-64-2 H 003-05 8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) 5 μmol ~1.8 mg 31356-95-3 H 003-25 8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) 5 x 5 μmol 31356-95-3 H 004-01 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) 1 μmol ~0.4 mg 755748-37-9 H 004-05 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) 5 x 1 μmol 755748-37-9 H 005-05 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) 5 μmol ~1.9 mg 749843-87-6 H 005-25 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) 5 x 5 μmol 749843-87-6 H 006-05 8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) 5 μmol ~2.3 mg 59212-44-1 H 006-25 8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) 5 x 5 μmol 59212-44-1 H 007-100 8- Hydroxyadenine ( 8-OH-Ade ) 100 μmol ~15 mg 21149-26-8 H 007-500 8- Hydroxyadenine ( 8-OH-Ade ) 5 x 100 μmol 21149-26-8 H 010-05 8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) 5 μmol ~2.4 mg 612513-15-2 H 010-25 8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) 5 x 5 μmol 612513-15-2 H 011-05 8- Hydroxyadenosine ( 8-OH-Ado ) 5 μmol ~1.4 mg 29851-57-8 H 011-25 8- Hydroxyadenosine ( 8-OH-Ado ) 5 x 5 μmol 29851-57-8 H 013-05 8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) 5 μmol ~1.9 mg pending H 013-25 8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) 5 x 5 μmol pending I 001-250 Inosine- 3', 5'- cyclic monophosphate ( cIMP ) 5 x 50 μmol 41092-64-2 I 001-50 Inosine- 3', 5'- cyclic monophosphate ( cIMP ) 50 μmol ~18 mg 41092-64-2 I 004-05 5- Iodotubercidin / 7- Deaza- 7- iodoadenosine ( 5-I-Tu ) 5 μmol ~2 mg 4386-93- I 004-25 5- Iodotubercidin / 7- Deaza- 7- iodoadenosine ( 5-I-Tu ) 5 x 5 μmol 4386-93- K 001-48 Ko-Libri Library of Nucleosides and Nucleobases 48 x 250 μl pending M 001-10 8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) 10 μmol ~3.8 mg 33823-18-6 M 001-50 8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) 5 x 10 μmol 33823-18-6 M 003-250 N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) 5 x 50 μmol 70253-67-7 M 003-50 N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) 50 μmol ~21 mg 70253-67-7 M 004-05 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) 5 μmol ~2.2 mg 152218-23-0 M 004-25 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) 5 x 5 μmol 152218-23-0 M 005-05 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) 5 μmol ~2.2 mg 152218-23-0 M 005-25 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) 5 x 5 μmol 152218-23-0 M 006-10 2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( MB-cGMP ) 10 μmol ~4.4 mg 58329-72-9 M 006-50 2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( MB-cGMP ) 5 x 10 μmol 58329-72-9 M 007-250 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2-MB-cAMP ) 5 x 50 μmol 55443-13-5 M 007-50 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2-MB-cAMP ) 50 μmol ~21 mg 55443-13-5 M 008-10 2'- O- ( N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) 10 μmol ~4.8 mg 83707-14-6 M 008-50 2'- O- ( N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) 5 x 10 μmol 83707-14-6 M 009-10 2'- O- ( N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) 10 μmol ~5 mg 83707-15-7 M 009-50 2'- O- ( N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) 5 x 10 μmol 83707-15-7 M 011-125 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) 5 x 25 μmol 36940-87-1 M 011-25 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) 25 μmol ~11 mg 36940-87-1 M 012-05 N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) 5 μmol ~2.3 mg 84433-46-5 M 012-25 N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) 5 x 5 μmol 84433-46-5 M 015-125 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) 5 x 25 μmol 39118-26-8 M 015-25 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) 25 μmol ~12 mg 39118-26-8 M 016-05 8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) 5 μmol ~2.9 mg 342029-95-2 M 016-25 8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) 5 x 5 μmol 342029-95-2 M 017-05 N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) 5 μmol ~2.9 mg 723313-27-7 M 017-25 N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) 5 x 5 μmol 723313-27-7 M 020-05 2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP ) 5 μmol ~2.4 mg 34983-48-7 M 020-25 2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP ) 5 x 5 μmol 34983-48-7 M 021-05 2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP ) 5 μmol ~2.8 mg 43170-89-4 M 021-25 2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP ) 5 x 5 μmol 43170-89-4 M 022-01 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) 1 μmol ~0.6 mg 104809-08-7 M 022-05 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) 5 x 1 μmol 104809-08-7 M 023-01 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) 1 μmol ~0.6 mg 104872-93-7 M 023-05 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) 5 x 1 μmol 104872-93-7 M 024-05 N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3MeBn)-ADP ) 5 μmol ~2.7 mg 681175-78-0 M 024-25 N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3MeBn)-ADP ) 5 x 5 μmol 681175-78-0 M 025-05 N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3MeBn)-ATP ) 5 μmol ~3.1 mg 215321-95-2 M 025-25 N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3MeBn)-ATP ) 5 x 5 μmol 215321-95-2 M 026-05 N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-1MeBu-ADP ) 5 μmol ~2.5 mg pending M 026-25 N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-1MeBu-ADP ) 5 x 5 μmol pending M 027-05 N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-1MeBu-ATP ) 5 μmol ~2.9 mg 252889-13-7 M 027-25 N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-1MeBu-ATP ) 5 x 5 μmol 252889-13-7 M 028-05 N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-2MeBu-ADP ) 5 μmol ~2.5 mg 681175-77-9 M 028-25 N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-2MeBu-ADP ) 5 x 5 μmol 681175-77-9 M 029-05 N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-2MeBu-ATP ) 5 μmol ~2.9 mg 252889-14-8 M 029-25 N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-2MeBu-ATP ) 5 x 5 μmol 252889-14-8 M 030-05 2'-/3'- O- (N- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) 5 μmol ~3.2 mg 151481-86-6 M 030-25 2'-/3'- O- (N- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) 5 x 5 μmol 151481-86-6 M 031-10 2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP ) 10 μmol ~3.9 mg 22140-20-1 M 031-50 2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP ) 5 x 10 μmol 22140-20-1 M 032-05 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) 5 μmol ~3.3 mg 148821-03-8 M 032-25 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) 5 x 5 μmol 148821-03-8 M 033-10 2- Methylthioadenosine ( 2-MeS-Ado ) 10 μmol ~3.1 mg 4105-39-9 M 033-50 2- Methylthioadenosine ( 2-MeS-Ado ) 5 x 10 μmol 4105-39-9 M 034-05 8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) 5 μmol ~2.5 mg 612513-16-3 M 034-25 8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) 5 x 5 μmol 612513-16-3 M 036-05 2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) 5 μmol ~1.9 mg pending M 036-25 2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) 5 x 5 μmol pending M 037-10 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) 10 μmol ~4.8 mg 85287-54-3 M 037-50 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) 5 x 10 μmol 85287-54-3 M 038-10 N6- Methyladenosine- 5'- O- monophosphate ( N6-5'-Me-AMP ) 10 μmol ~3.6 mg 81921-35-9 M 038-50 N6- Methyladenosine- 5'- O- monophosphate ( N6-5'-Me-AMP ) 5 x 10 μmol 81921-35-9 M 040-05 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) 5 μmol ~2.8 mg 151481-85-5 M 040-25 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) 5 x 5 μmol 151481-85-5 M 041-05 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) 5 μmol ~2.9 mg 148821-02-7 M 041-25 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) 5 x 5 μmol 148821-02-7 M 042-10 2'-, 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) 10 μmol ~5 mg 85287-54-3 M 042-50 2'-, 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) 5 x 10 μmol 85287-54-3 M 047-01 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(β, γ)- imido]triphosphate ( MANT-GppNHp ) 1 μmol ~0.7 mg 148821-01-6 M 047-05 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(β, γ)- imido]triphosphate ( MANT-GppNHp ) 5 x 1 μmol 148821-01-6 M 050-05 2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) 5 μmol ~1.8 mg 40269-29-2 M 050-25 2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) 5 x 5 μmol 40269-29-2 M 053-05 2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) 5 μmol ~2.3 mg pending M 053-25 2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) 5 x 5 μmol pending M 054-10 2'- O- Methyladenosine ( 2'-O-Me-Ado ) 10 μmol ~2.8 mg 2140-79-6 M 054-50 2'- O- Methyladenosine ( 2'-O-Me-Ado ) 5 x 10 μmol 2140-79-6 M 062-10 8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) 10 μmol ~4.0 mg pending M 062-50 8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) 5 x 10 μmol pending N 001-01 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) 1 μmol ~0.7 mg 115993-88-9 N 001-05 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) 5 x 1 μmol 115993-88-9 N 002-01 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) 1 μmol ~0.6 mg 221905-51-7 N 002-05 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) 5 x 1 μmol 221905-51-7 N 003-05 8- Nitroguanine ( 8-NO2-Gua ) 5 μmol ~1 mg 168701-80-2 N 003-25 8- Nitroguanine ( 8-NO2-Gua ) 5 x 5 μmol 168701-80-2 N 004-05 8- Nitroguanosine ( 8-NO2-Guo ) 5 μmol ~1.6 mg 337536-53-5 N 004-25 8- Nitroguanosine ( 8-NO2-Guo ) 5 x 5 μmol 337536-53-5 N 007-05 4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) 5 μmol ~1.9 mg 127634-21-3 N 007-25 4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) 5 x 5 μmol 127634-21-3 N 010-10 beta- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ε-NAD+ ) 10 μmol ~6.9 mg 38806-38-1 N 010-50 beta- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ε-NAD+ ) 5 x 10 μmol 38806-38-1 N 012-001 beta- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ), sodium salt 0.1 μmol ~0.12 mg pending N 012-005 beta- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ), sodium salt 5 x 0.1 μmol pending N 013-05 beta- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ), sodium salt 5 μmol ~3.5 mg 59587-50-7 N 013-25 beta- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ), sodium salt 5 x 5 μmol 59587-50-7 P 001-10 beta- Phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) 10 μmol ~4.7 mg 78080-27-0 P 001-50 beta- Phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) 5 x 10 μmol 78080-27-0 P 002-10 8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) 10 μmol ~4.3 mg 31357-06-9 P 002-50 8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) 5 x 10 μmol 31357-06-9 P 003-10 8- Bromo-ß-phenyl- 1, N²- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) 10 μmol ~5.5 mg 144510-04-3 P 003-50 8- Bromo-ß-phenyl- 1, N²- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) 5 x 10 μmol 144510-04-3 P 004-05 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) 5 μmol ~2.3 mg 156816-36-3 P 004-25 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) 5 x 5 μmol 156816-36-3 P 005-05 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) 5 μmol ~2.3 mg 156816-35-2 P 005-25 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) 5 x 5 μmol 156816-35-2 P 006-05 N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) 5 μmol ~2.1 mg 34051-30-4 P 006-25 N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) 5 x 5 μmol 34051-30-4 P 007-01 8- Bromo- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) 1 μmol ~0.6 mg 172806-20-1 P 007-05 8- Bromo- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) 5 x 1 μmol 172806-20-1 P 008-05 8- Bromo- β -phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) 5 μmol ~2.8 mg 172806-21-2 P 008-25 8- Bromo- β -phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) 5 x 5 μmol 172806-21-2 P 009-05 Purine riboside- 5'- O- triphosphate ( PuTP ) 5 μmol ~2.5 mg 23197-96-8 P 009-25 Purine riboside- 5'- O- triphosphate ( PuTP ) 5 x 5 μmol 23197-96-8 P 010-05 Purine riboside- 3', 5'- cyclic monophosphate ( cPuMP ) 5 μmol ~1.7 mg 53303-84-7 P 010-25 Purine riboside- 3', 5'- cyclic monophosphate ( cPuMP ) 5 x 5 μmol 53303-84-7 P 011-05 Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) 5 μmol ~1.6 mg 13484-60-1 P 011-25 Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) 5 x 5 μmol 13484-60-1 P 012-05 N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) 5 μmol ~3.1 mg 181705-62-4 P 012-25 N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) 5 x 5 μmol 181705-62-4 P 013-05 N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) 5 μmol ~2.7 mg 681175-76-8 P 013-25 N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) 5 x 5 μmol 681175-76-8 P 014-05 N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) 5 μmol ~2.5 mg 105701-92-6 P 014-25 N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) 5 x 5 μmol 105701-92-6 P 015-05 N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) 5 μmol ~2.9 mg 105740-47-4 P 015-25 N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) 5 x 5 μmol 105740-47-4 P 018-05 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) 5 μmol ~2.2 mg 169335-92-6 P 018-25 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) 5 x 5 μmol 169335-92-6 P 019-001 8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cAMP ) 0.1 μmol ~72 μg pending P 019-005 8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cAMP ) 5 x 0.1 μmol pending P 020-001 8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cGMP ) 0.1 μmol ~74 μg pending P 020-005 8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cGMP ) 5 x 0.1 μmol pending P 021-001 8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-2'-O-Me-cAMP ) 0.1 μmol ~74 μg pending P 021-005 8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-2'-O-Me-cAMP ) 5 x 0.1 μmol pending P 023-001 5'- Phosphoguanylyl- (3' → 5')- guanosine ( pGpG ) 0.1 μmol ~71 μg 33008-99-0 P 023-005 5'- Phosphoguanylyl- (3' → 5')- guanosine ( pGpG ) 5 x 0.1 μmol 33008-99-0 P 024-001 8- [Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cAMP ) 0.1 μmol ~72 μg pending P 024-005 8- [Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cAMP ) 5 x 0.1 μmol pending P 025-001 8- [Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cGMP ) 0.1 μmol ~74 μg pending P 025-005 8- [Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cGMP ) 5 x 0.1 μmol pending P 026-05 N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-γ-S ) 5 μmol ~3.1 mg pending P 026-25 N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-γ-S ) 5 x 5 μmol pending P 032-10 8- Phenylthioadenosine ( 8-PT-Ado ) 10 μmol ~3.8 mg pending P 032-50 8- Phenylthioadenosine ( 8-PT-Ado ) 5 x 10 μmol pending T 002-05 Thymidine- 5'- O- (1-thiotriphosphate), Rp-isomer ( Rp-TTP-α-S ) 5 μmol ~2.5 mg 83199-35-3 T 002-25 Thymidine- 5'- O- (1-thiotriphosphate), Rp-isomer ( Rp-TTP-α-S ) 5 x 5 μmol 83199-35-3 T 003-05 Thymidine- 5'- O- (1-thiotriphosphate), Sp-isomer ( Sp-TTP-α-S ) 5 μmol ~2.5 mg 83199-32-0 T 003-25 Thymidine- 5'- O- (1-thiotriphosphate), Sp-isomer ( Sp-TTP-α-S ) 5 x 5 μmol 83199-32-0 T 004-05 Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) 5 μmol ~1.6 mg 15548-51-3 T 004-25 Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) 5 x 5 μmol 15548-51-3 T 005-05 Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) 5 μmol ~1.6 mg 76567-90-3 T 005-25 Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) 5 x 5 μmol 76567-90-3 T 008-05 Thymidine- 5'- O- (α, β- methylene)diphosphate ( TMP-CP ) 5 μmol ~2 mg 55065-40-2 T 008-25 Thymidine- 5'- O- (α, β- methylene)diphosphate ( TMP-CP ) 5 x 5 μmol 55065-40-2 T 009-05 N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) 5 μmol ~1.9 mg 40027-70-1 T 009-25 N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) 5 x 5 μmol 40027-70-1 T 010-05 5'- [(2, 2, 5, 5- Tetramethyl- 3- pyrrolin- 1- oxyl- 3- carboxylamino)adenosine ( 5'-TMPO-Ado ) 5 μmol ~2.2 mg pending T 010-25 5'- [(2, 2, 5, 5- Tetramethyl- 3- pyrrolin- 1- oxyl- 3- carboxylamino)adenosine ( 5'-TMPO-Ado ) 5 x 5 μmol pending T 012-05 Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate 5 μmol ~2 mg [2863-04-9] T 012-25 Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate 5 x 5 μmol [2863-04-9] U 001-250 Uridine- 3', 5'- cyclic monophosphate ( cUMP ) 5 x 50 μmol 56632-58-7 U 001-50 Uridine- 3', 5'- cyclic monophosphate ( cUMP ) 50 μmol ~16 mg 56632-58-7 U 002-05 Uridine- 5'- O- (1-thiotriphosphate), Rp- isomer ( Rp-UTP-α-S ) 5 μmol ~2.5 mg 71214-30-4 U 002-25 Uridine- 5'- O- (1-thiotriphosphate), Rp- isomer ( Rp-UTP-α-S ) 5 x 5 μmol 71214-30-4 U 003-05 Uridine- 5'- O- (1-thiotriphosphate), Sp- isomer ( Sp-UTP-α-S ) 5 μmol ~2.5 mg 71214-29-4 U 003-25 Uridine- 5'- O- (1-thiotriphosphate), Sp- isomer ( Sp-UTP-α-S ) 5 x 5 μmol 71214-29-4 U 004-250 Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) 5 x 50 μmol 15718-50-0 U 004-50 Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) 50 μmol ~16 mg 15718-50-0 U 006-05 Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) 5 μmol ~1.7 mg 15548-52-4 U 006-25 Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) 5 x 5 μmol 15548-52-4 U 008-01 P1- (5'- Adenosyl)- P4- (5'- uridyl)- tetraphosphate / Uridine- adenosine- 5'- tetraphosphate ( Up4A ) 1 μmol ~0.8 mg 10527-48-7 U 008-05 P1- (5'- Adenosyl)- P4- (5'- uridyl)- tetraphosphate / Uridine- adenosine- 5'- tetraphosphate ( Up4A ) 5 x 1 μmol 10527-48-7 U 009-05 Uridine- 5'- O- (α, β- methylenediphosphate) ( UMP-CP ) 5 μmol ~2 mg 732921-73-2 U 009-25 Uridine- 5'- O- (α, β- methylenediphosphate) ( UMP-CP ) 5 x 5 μmol 732921-73-2 U 010-05 Uridine- 5'- O- (3- thiotriphosphate) ( UTP-gamma-S ), sodium salt 5 μmol ~2.5 mg 79049-97-1 U 010-25 Uridine- 5'- O- (3- thiotriphosphate) ( UTP-gamma-S ), sodium salt 5 x 5 μmol 79049-97-1 X 001-05 Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) 5 μmol ~1.8 mg 31319-70-7 X 001-25 Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) 5 x 5 μmol 31319-70-7